Drug intelligence / Profile preview

autologous bone marrow-derived mesenchymal stem cells (Rush University Medical Center)

Development stage
Unknown
Lead developer
Rush University Medical Center
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intralesional
01

Overview

This investigational cell-based therapy, developed by Rush University Medical Center, utilizes autologous bone marrow-derived mesenchymal stem cells (MSCs) to augment arthroscopic repair of full-thickness rotator cuff tears. The procedure involves extracting bone marrow from the patient's hip, concentrating the MSCs via centrifugation, and injecting the resulting concentrate into the tendon-bone junction and the surgical footprint. These MSCs facilitate healing by differentiating into specialized cell types such as tenocytes, chondrocytes, and osteoblasts, while also secreting essential growth factors that promote tissue regeneration and enhance the structural integrity of the tendon-to-bone interface.

Other names
mesenchymal stem cell augmentationMSC augmentationbone marrow-derived mesenchymal stem cells

Beyond the preview

Go deeper on autologous bone marrow-derived mesenchymal stem cells (Rush University Medical Center).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous bone marrow-derived mesenchymal stem cells (Rush University Medical Center).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call